Ulisse Biomed Spa
MIL:UBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
KR |
|
Heritage Commerce Corp
NASDAQ:HTBK
|
US |
|
N
|
Nippon Express Holdings Inc
TSE:9147
|
JP |
|
B
|
Banque Cantonale de Geneve
SIX:BCGE
|
CH |
|
Paramita Bangun Sarana Tbk PT
IDX:PBSA
|
ID |
|
P
|
PT Multi Makmur Lemindo Tbk
IDX:PIPA
|
ID |
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
CN |
|
S
|
Surgical Science Sweden AB
STO:SUS
|
SE |
|
Wingtech Technology Co Ltd
SSE:600745
|
CN |
Bankruptcy Probability
Ulisse Biomed Spa's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ulisse Biomed Spa Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IT |
|
Ulisse Biomed Spa
MIL:UBM
|
19.5m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ulisse Biomed Spa's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ulisse Biomed Spa has total debt of 1m EUR. This includes both short-term (0 EUR) and long-term (1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
